Absence of thromboembolic complications in patients with hereditary bleeding disorders undergoing major orthopaedic surgery without antithrombotic prophylaxis.
نویسندگان
چکیده
1053 Dear Sir, aÉÉé îÉáå íÜêçãÄçëáë EasqF áë ~ ÑêÉèìÉåí ÅçãéäáÅ~íáçå áå é~íáÉåíë ìåÇÉêÖçáåÖ ã~àçê ëìêÖÉêó ïáíÜ ~ ã~ñáãìã éÉ~â áåÅáÇÉåÅÉ Eìé íç SMJTMBF ~ÑíÉê Üáé ~åÇ âåÉÉ êÉéä~ÅÉãÉåíë ENI OFK qÜÉ áåíêçÇìÅíáçå çÑ ÜÉé~êáå ~åíáÅç~Öìä~åí éêçéÜóä~ñáë Ü~ë Çê~ã~íáÅ~ääó êÉÇìÅÉÇ íÜÉ çÅÅìêêÉåÅÉ çÑ éçëíçéÉê~íáîÉ asq ~åÇ áí áë åçï~Ç~óë ëí~åÇ~êÇ Å~êÉ Ñçê ~ää é~íáÉåíë ìåÇÉêÖçáåÖ ëìêÖÉêó íÜ~í Å~êêáÉë ~ íÜêçãÄçíáÅ êáëâ EPFK eçïÉîÉêI íÜÉ ÖêÉ~í ã~àçêáíó çÑ íÜÉ ëíìÇáÉë éìÄäáëÜÉÇ ëç Ñ~ê çå íÜáë íçéáÅ êÉÑÉê íç é~íáÉåíë ïáíÜçìí ~Äåçêã~äáíáÉë çÑ Ü~Éãçëí~ëáëI ~åÇ îÉêó äáííäÉ Ç~í~ ~êÉ ~î~áä~ÄäÉ êÉÖ~êÇáåÖ íÜÉ çÅÅìêêÉåÅÉ çÑ éçëíçéÉê~íáîÉ íÜêçãÄçÉãÄçäáÅ ÅçãéäáÅ~íáçåë ~åÇ íÜÉ åÉÉÇ Ñçê ~åíáíÜêçãÄçíáÅ éêçéÜóä~ñáë áå é~íáÉåíë ïáíÜ ÜÉêÉÇáí~êó ÄäÉÉÇáåÖ ÇáëçêÇÉêë EQJTFK qÜáë éêçÄäÉã áëI áå çìê çéáåáçåI é~êíáÅìä~êäó êÉäÉî~åí Ñçê çêíÜçé~ÉÇáÅ ëìêÖáÅ~ä éêçÅÉÇìêÉëI ëáåÅÉ Ü~ÉãçéÜáäá~Åë ïáíÜ ãçêÉ ëÉîÉêÉ ÇáëÉ~ëÉ çÑíÉå ìåÇÉêÖç îÉêó ÇÉã~åÇáåÖ çêíÜçé~ÉÇáÅ çéÉê~íáçåë ÄÉÅ~ìëÉ çÑ ëÉîÉêÉ Ü~ÉãçéÜáäáÅ ~êíÜêçé~íÜó EUFK få íÜáë êÉíêçëéÉÅíáîÉ ëíìÇóI ïÉ êÉîáÉïÉÇ íÜÉ Ç~í~ Ñêçã TU ÅçåëÉÅìíáîÉ é~íáÉåíë ESU ã~äÉë ~åÇ NM ÑÉã~äÉëI ãÉÇá~å ~ÖÉ QMKO óÉ~êëI ê~åÖÉ VJTP óÉ~êëF ïáíÜ ÜÉêÉÇáí~êó ÄäÉÉÇáåÖ ÇáëçêÇÉêëI ÑçääçïÉÇ ~í íÜêÉÉ fí~äá~å e~ÉãçéÜáäá~ `ÉåíêÉë EqêÉåíçI sÉêçå~ ~åÇ m~êã~FI ïÜç ìåÇÉêïÉåí VP ã~àçê çêíÜçé~ÉÇáÅ ëìêÖáÅ~ä éêçÅÉÇìêÉë ïáíÜçìí ~åíáíÜêçãÄçíáÅ éêçéÜóä~ñáë ÄÉíïÉÉå g~åì~êó NVUR ~åÇ gìäó OMMPK lÑ íÜÉ TU é~íáÉåíë Éî~äì~íÉÇI RR Ü~Ç Ü~ÉãçéÜáäá~ ^ EPS ïáíÜ ëÉîÉêÉ ÇáëÉ~ëÉ xÑ~Åíçê sfff Åç~Öìä~åí ~ÅíáîáíóI csfffW` YNBzI NP ïáíÜ ãçÇÉê~íÉ ÇáëÉ~ëÉ xcsfffW` ÄÉíïÉÉå NB ~åÇ RBzI S ïáíÜ ãáäÇ ÇáëÉ~ëÉ xcsfffW` [RBzFI NN Ü~Ç Ü~ÉãçéÜáäá~ _ EU ïáíÜ ëÉîÉêÉ ÇáëÉ~ëÉ xÑ~Åíçê fu Åç~Öìä~åí ~ÅíáîáíóI cfuW` YNBzI P ïáíÜ ãáäÇ ÇáëÉ~ëÉ xcfuW` [RBzF ~åÇ NO Ü~Ç îçåtáääÉÄê~åÇÛë ÇáëÉ~ëÉ EstaF EV íóéÉ fI P íóéÉ ff staFK jÉ~å csfffW`I îçå táääÉJ Äê~åÇ Ñ~Åíçê ~åíáÖÉå EstcW^ÖF ~åÇ îçå táääÉÄê~åÇ Ñ~ÅíçêW êáëíçÅÉíáå ÅçÑ~Åíçê EstcWo`çF áå é~íáÉåíë ïáíÜ sta ïÉêÉ PMKP frLÇä Eê~åÖÉI SJTU frLÇäFI NTKM Eê~åÖÉI MJTS frLÇäF ~åÇ NRKQ Eê~åÖÉI MJPS frLÇäFI êÉëéÉÅíáîÉäóK q~ÄäÉ N äáëíë íÜÉ çêíÜçé~ÉÇáÅ çéÉê~íáçåë ~ÅÅçêÇáåÖ íç íÜÉ ÇáÑÑÉêÉåí íóéÉë çÑ ÜÉêÉÇáí~êó ÄäÉÉÇáåÖ ÇáëçêÇÉêK kç é~íáÉåí êÉÅÉáîÉÇ íÜêçãÄçéêçéÜóä~ñáë ÇìêáåÖ ëìêÖÉêó çê íÜÉ éçëíJçéÉê~íáîÉ éÉêáçÇK ^ë êÉÖ~êÇë êÉéä~ÅÉJ ãÉåí íÜÉê~éóI éä~ëã~JÇÉêáîÉÇ Ñ~Åíçê sfff çê fu ÅçåÅÉåíê~íÉ ï~ë ìëÉÇ áå SO Å~ëÉë ïÜÉêÉ~ë ~ êÉÅçãÄáå~åí éêçÇìÅí ï~ë ìëÉÇ áå íÜÉ êÉã~áåáåÖ PN Å~ëÉëK kç é~íáÉåí Ü~Ç áåÜáÄáíçêë íç Åç~Öìä~íáçå Ñ~ÅJ íçêëK qÜÉ ÇçëáåÖ êÉÖáãÉåë çÑ ÅäçííáåÖ Ñ~Åíçê ÅçåÅÉåíê~íÉë ìëÉÇ Ñçê íÜÉ ÇáÑÑÉêÉåí áåíÉêîÉåíáçåë ïÉêÉ íÜçëÉ ~ééêçîÉÇ Äó íÜÉ fí~äá~å ^ëëçÅá~íáçå çÑ e~ÉãçéÜáäá~ `ÉåíêÉë E^f`bFK få é~êíáÅìä~êI ~å áåáíá~ä ÇçëÉ çÑ RMJNMM rLâÖ çÑ Ñ~Åíçê ÅçåÅÉåíê~íÉ ï~ë ~ÇãáåáëJ íÉêÉÇ áå çêÇÉê íç ~ÅÜáÉîÉ éä~ëã~ Ñ~Åíçê äÉîÉäë ~ÄçîÉ UMJNMMB ~åÇ íç ã~áåí~áå íÜÉëÉ äÉîÉäë Ñçê ~í äÉ~ëí TO ÜçìêëK qÜÉ ÇçëÉ ï~ë íÜÉå ~ÇàìëíÉÇ íç ã~áåí~áå éä~ëã~ Ñ~Åíçê äÉîÉäë ~ÄçîÉ RMB Ñçê íÜÉ åÉñí TJNR Ç~óëK qÜÉ Åç~Öìä~íáçå é~ê~ãÉíÉêë ïÉêÉ ãçåáíçêÉÇ ÄÉÑçêÉ ~åÇ ~ÑíÉê áåÑìëáçå çÑ íÜÉ Ñ~Åíçê ÅçåÅÉåíê~íÉK qêÉ~íãÉåí çìíÅçãÉ ï~ë ê~íÉÇ ~ë ÉñÅÉääÉåí E~ÅÜáÉîÉãÉåí çÑ åçêã~ä Ü~Éãçëí~ëáëFI ÖççÇ EãáäÇäó ~Äåçêã~ä Ü~Éãçëí~ëáë åçí êÉèìáêáåÖ ~ÇÇáíáçå~ä íÜÉê~éóFI çê éççê EÜ~Éãçëí~ëáë äÉëë íÜ~å ÉñéÉÅíÉÇF ~ë ~ ãÉ~ëìêÉ çÑ çîÉê~ää ÉÑÑáÅ~ÅóK páñ é~íáÉåíë EO ïáíÜ ãáäÇ Ü~ÉãçéÜáäá~ ^ ~åÇ Q ïáíÜ íóéÉ f staF ïÉêÉ ~äëç ÅçåÅçãáí~åíJ äó íêÉ~íÉÇ ïáíÜ ÇÉëãçéêÉëëáå ïÜÉêÉ~ë ~åíáÑáÄêáåçäóíáÅ ÇêìÖë Eíê~åÉñ~ãáÅ ~ÅáÇF ïÉêÉ ÖáîÉå íç Q é~íáÉåíëI ~ää ïáíÜ ëÉîÉêÉ Ü~ÉãçéÜáäá~ ^K qïÉåíóJëáñ é~íáÉåíë ïÉêÉ íê~åëÑìëÉÇ EU é~íáÉåíë ïáíÜ ~ìíçäçÖçìë êÉÇ ÄäççÇ ÅÉääë xãÉÇá~å åìãÄÉê çÑ ~ìíçäçÖçìë ÄäççÇ ìåáíë íê~åëÑìëÉÇW OKOI ê~åÖÉ NJQ ìåáíëzI NS é~íáÉåíë ïáíÜ ~ääçÖÉåÉáÅ êÉÇ ÄäççÇ ÅÉääë xãÉÇá~å åìãÄÉê çÑ ~ääçÖÉåÉáÅ ÄäççÇ ìåáíë íê~åëÑìëÉÇW OKQI ê~åÖÉ NJS ìåáíëz ~åÇ O é~íáÉåíë ïáíÜ ÑêÉëÜJ ÑêçòÉå éä~ëã~FK ^åó ÄäÉÉÇáåÖ çê íÜêçãÄçíáÅ ÉéáëçÇÉ çÅÅìêêáåÖ ÇìêáåÖ çê ~ÑíÉê ëìêÖÉêó ï~ë ÇçÅìãÉåíÉÇK a~í~ ïÉêÉ êÉíêáÉîÉÇ Ñêçã ãÉÇáÅ~ä êÉÅçêÇë ~åÇ íÜÉ êÉíêçëéÉÅíáîÉ ~å~äóëáë ï~ë ÉñíÉåÇÉÇ ìé íç P ãçåíÜë ~ÑíÉê ÇáëÅÜ~êÖÉI áå çêÇÉê íç áÇÉåíáÑó ä~íÉ íÜêçãÄçÉãÄçäáÅ ÅçãéäáÅ~íáçåëK qÜÉ ãÉÇá~å Çìê~íáçå çÑ Ñ~Åíçê ÅçåÅÉåíê~íÉ íêÉ~íãÉåí ï~ë NNKS Ç~óë Eê~åÖÉ RJOP Ç~óëFK qÜÉ é~íáÉåíë ïáíÜ Ü~ÉãçéÜáäá~ ^ êÉÅÉáîÉÇ ~ ãÉ~å íçí~ä ÇçëÉ çÑ csfff ÅçåÅÉåíê~íÉ çÑ PTTNMKR œ NQTPQKN fr ~åÇ ~ ãÉÇá~å åìãÄÉê çÑ áåÑìëáçåë éÉê çéÉê~íáçå çÑ NRKR œ SKVK qÜÉ ãÉÇá~å éçëíJáåÑìëáçå äÉîÉä çÑ csfffW` ï~ë VQKT frLÇä Eê~åÖÉ RRJNUU frLÇäFK qÜÉ é~íáÉåíë ïáíÜ Ü~ÉãçéÜáäá~ _ êÉÅÉáîÉÇ ~ ãÉ~å íçí~ä ÇçëÉ çÑ cfu ÅçåÅÉåíê~íÉ çÑ PSNQOKV œ NRRUSKS fr ~åÇ ~ ãÉ~å åìãÄÉê çÑ áåÑìëáçåë éÉê çéÉê~íáçå çÑ NNKO œ RKUK qÜÉ ãÉÇá~å éçëíJáåÑìëáçå äÉîÉä çÑ cfuW` ï~ë UMKN frLÇä Eê~åÖÉ RMJNOO frLÇäFK qÜÉ é~íáÉåíë ïáíÜ îçå táääÉJ Äê~åÇÛë ÇáëÉ~ëÉ êÉÅÉáîÉÇ ~ ãÉ~å íçí~ä ÇçëÉ çÑ csfffLstc ÅçåÅÉåíê~íÉ çÑ OTSQOKV œ NOMVUKN fr ~åÇ ~ ãÉ~å åìãÄÉê çÑ áåÑìëáçåë éÉê çéÉê~íáçå çÑ NQKQ œ RKQK qÜÉ ãÉÇá~å éçëíJáåÑìëáçå csfffW`I stcW^Ö ~åÇ tscWo`ç äÉîÉäë ïÉêÉ NMQKO frLÇä Eê~åÖÉ RSJNUR frLÇäFI UTKN frLÇä Eê~åÖÉ ROJNSS frLÇäF ~åÇ UPKQ frLÇä Eê~åÖÉ RMJNQM frLÇäFI êÉëéÉÅíáîÉäóK Absence of thromboembolic complications in patients with hereditary bleeding disorders undergoing major orthopaedic surgery without antithrombotic prophylaxis
منابع مشابه
Chapter 12 Coagulation, Thromboembolism, and Blood Management in Orthopaedic Surgery
Venous thromboembolic disease and prophylaxis are subjects of controversy in orthopaedic surgery. Venous thromboembolism is a major risk in patients undergoing total hip and knee arthroplasty as well as repair of a hip fracture. In addition, patients sustaining major orthopaedic trauma including spinal cord injury as well as patients undergoing treatment of various other musculoskeletal conditi...
متن کاملRivaroxaban for Thromboprophylaxis After Nonelective Orthopedic Trauma Surgery in Switzerland.
This study investigated the effectiveness and the outcomes of rivaroxaban vs the standard of care for venous thromboembolic prophylaxis in patients undergoing fracture-related surgery. A total of 413 patients undergoing fracture-related surgery from 9 Swiss orthopedic and trauma centers were enrolled. The authors selected the type of venous thromboembolic prophylaxis according to standardized m...
متن کاملManagement of antithrombotic therapies in patients scheduled for eye surgery.
The large majority of patients undergoing ophthalmic surgery are elderly and take systemic medications on a regular basis, including antiplatelet and anticoagulant treatments. It is current practice for many physicians to discontinue antithrombotic treatment prior to surgery to reduce bleeding complications that may lead to retrobulbar haemorrhage and, ultimately, to loss of vision. However, di...
متن کامل[Thromboembolic disease in orthopedic surgery].
Thromboembolic complications are frequent after orthopaedic surgery of the limbs. Strategies to minimize these complications go from recognize the risk factors of the patient to introduce new antithrombotic drugs, and including general medical care, regional anaesthesia and early mobilization. Based in epidemiological studies, prophylaxis must be extended 4-6 weeks in total hip and knee arthrop...
متن کاملThe effects of timing of prophylaxis, type of anesthesia, and use of mechanical methods on outcome in major orthopedic surgery – subgroup analyses from 17,701 patients in the XAMOS study
PURPOSE Real-world data on the use of rivaroxaban in the perioperative period in patients undergoing major orthopedic surgery are limited. Subsets of data from the Phase IV, non-interventional XAMOS study were analyzed to explore the potential influence of timing of the first thrombo prophylactic dose, type of anesthesia, and concomitant mechanical prophylaxis on clinical outcomes in patients u...
متن کاملBleeding complications during cardiac electronic device implantation in patients receiving antithrombotic therapy: is there any value of local tranexamic acid?
BACKGROUND The perioperative use of antithrombotic therapy is associated with increased bleeding risk after cardiac implantable electronic device (CIED) implantation. Topical application of tranexamic acid (TXA) is effective in reducing bleeding complications after various surgical operations. However, there is no information regarding local TXA application during CIED procedures. The purpose o...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- Thrombosis and haemostasis
دوره 91 5 شماره
صفحات -
تاریخ انتشار 2004